Economic evaluation of screening for diabetic retinopathy among Chinese type 2 diabetics: A community-based study in Kinmen, Taiwan

Journal of Epidemiology

Volumn 18, Issue 5, 2008, Pages 225-233

  Tung, Tao Hsin ^a,b   Shih, Hui Chuan ^c   Chen, Shih Jen ^d   Chou, Pesus ^e   Liu, Chi Ming ^a   Liu, Jorn Hon ^a,e,f  

^a CHENG HSIN REHABILITATION MEDICAL CENTER   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c KAOHSIUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^d Department of Ophthalmology

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

^f CHENG HSIN GENERAL HOSPITAL   (Taiwan)

Author keywords

Costs and cost analysis; Diabetes mellitus type 2; Diabetic retinopathy; Mass screening; Population

Indexed keywords

ARTICLE; CHINA; COST BENEFIT ANALYSIS; DIABETIC RETINOPATHY; ECONOMICS; ETHNOLOGY; FEASIBILITY STUDY; HUMAN; MASS SCREENING; NON INSULIN DEPENDENT DIABETES MELLITUS; TAIWAN;

CHINA; COST-BENEFIT ANALYSIS; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEASIBILITY STUDIES; HUMANS; MASS SCREENING; TAIWAN;

EID: 56649112718     PISSN: 09175040     EISSN: 13499092     Source Type: Journal    
DOI: 10.2188/jea.JE2007439     Document Type: Article

References (25)

1. Schermthaner G. Cardiovascular mortality and morbidity in type 2 diabetes mellitus. Diabetes Res Clin Pract 1996;13:S3-13.
2. Sanchez-Thorin JC. The epidemiology of diabetes mellitus and diabetic retinopathy. Int Ophthalmol Clin 1998;38:11-8.
3. Chen MS, Kao CS, Chang CJ, Wu TJ, Fu CC, Chen CJ. Prevalence and risk factors of diabetic retinopathy among non-insulin-dependent diabetic subjects. Am J Ophthalmol 1992;114:723-30.
4. Tung TH, Chen SJ, Liu JH Lee FL, Li AF, Shyong MF et al. A community-based follow-up study on diabetec retinopathy among type 2 diabetics in Kinmen. Eur J Epidemiol. 2005;20:317-21
5. Lin T, Chou P., Lai MS, Tsai ST, Tai TY. Direct costs-of-illness of patients with diabetes mellitus in Taiwan. Diabetes Res Clin Pract 2001;39(suppl 1):S43-6.
6. Chou P, Liao MJ, Kuo HS, Hsiao KJ, Tsai ST. A population survey on the prevalence of diabetes in Kin-Hu, Kinmen. Diabetes Care 1994;17:1055-8.
7. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: Report of a WHO Consultation. Part 1. Diagnosis and classification of diabetes mellitus. Geneva: World Health Organization; 1999.
8. Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. ETDRS Report No. 9. Ophthalmology 1991;98:766-85.
9. Wilkinson CP, Ferris FL, Klein RE, Lee PP, Agardh CD, Davis M, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003;110:1677-82.
10. Tsai CY, Woung LC, Chou P, Yang CS, Shen MM, Wu JR, et al. The current status of visual disability in the elderly population of Taiwan. Jpn J Ophthalmol 2005;49:166-72.
11. Byrt T. How good is that agreement? Epidemiology 1996;7:561.
12. Tung TH, Chen SJ, Shih HC, Chou P, Li AF, Shyong MP, et al. Assessing the natural course of diabetic retinopathy: a population-based study in Kinmen, Taiwan. Ophthalmic Epidemiol 2006;13:327-33.
13. Tung TH, Chen SJ, Lee FL, Liu JH, Lin CH, Chou P. A community-based study for the utility values associated with diabetic retinopathy among type 2 diabetics in Kinmen, Taiwan. Diabetes Res Clin Pract 2005;68:265-73.
14. Brown MM, Brown GC, Sharma S, Shah G. Utility values and diabetic retinopathy. Am J Ophthalmol 1999;128:324-30.
15. Brown MM, Brown GC, Sharma S, Busbee B, Brown H. Quality of life associated with unilateral and bilateral good vision. Ophthalmology 2001;108:643-8.
16. Maberley D, Walker H, Koushik A, Cruess A. Screening for diabetic retinopathy in James Bay, Ontario: a cost-effectiveness analysis. CMAJ 2003;168:160-4.
17. Vijan S. Hofer TP. Havward RA. Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus. JAMA 2000;283:889-96.
18. Javitt JC, Aiello LP. Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med 1996;124:164-9.
19. Polak BC, Crijns H, Casparie AF, Niessen LW. Cost-effectiveness of glycemic control and ophthalmological care in diabetic retinopathy. Health Policy 2003;64:89-97.
20. Ackerman SJ. Benefits of preventive programs in eye care are visible on the bottom line. A new nationwide effort to improve eye care for people with diabetes gets backing from a study on the cost-effectiveness of screening, for retinopathy. Diabetes Care 1992;15:580-1.
21. Health Employer Data and Information Set. Version 3.0. Washington, DC: National Committee for Quality Assurance; 1997 p. 2.
22. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more, Arch Ophthalmol 1989;107:244-9.
23. Aiello LP, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL, et al. Diabetic retinopathy. Diabetes Care 1998;21:143-56.
24. Klein R, Klein BE, Neider MW, Hubbard LD, Meuer SK Brothers RJ. Diabetic retinopathy as detected using opththalmoscopy, a nonmydriatic camera and a standard fundus camera. Ophthalmology 1985;92:485-91.
25. Ekoe JM, Zimmet P, Williams R. The epidemiology of diabetes mellitus: An international perspective. Chichester, UK: John Wiley & Sons, Inc., 605 Third Avenue; 2001.